Abstract
Colon-targeted cell-permeable IKK-activated GSK3β inhibitory peptide (CTP-IAGIP in a colon-targeted capsule) is an inflammation-responsive anti-colitic therapeutics.
Funding Information
  • Ministry of Education (2018R1D1A3B07045694)

This publication has 43 references indexed in Scilit: